Food allergy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children aged 6 months or older, 6 years or younger Children who were diagnosed with a positive by open oral food challenge (OFC) with boiled egg white / milk, which total dose of 1-10 g. Excluding positive only for the symptoms around the oral cavity. There are blood test results within 3 months of OFC which performed prior to study registration. Children who can be Track one year and track confirmation OFC one year later. A person who consented to the study by a substitute person who is a parental author in writing.
Exclusion criteria
Exclusion criteria: Children already doing oral immunotherapy for the relevant foods, including irregular processed goods. Children who intake the other allergic food for oral immunotherapy within 2 hours of food intake for this trial. Those with poor control of atopic dermatitis and bronchial asthma. Children with chronic urticaria. Children who is planning to move within 1 year. The cases who have serious complications and doctor determines that it is inappropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference of amount of intake in oral food challenge after 12 +- 2 months from start of low dose oral immunotherapy between frequent (daily intake) group and intermittent (twice weekly intake) group. | — |
Secondary
| Measure | Time frame |
|---|---|
| Primary outcome which divided into subgroup of egg allergy and milk allergy. Difference of Egg white and ovomucoid-sIgE or milk and casein-sIgE after 12 +- 2 months from start the OIT between the frequent and the intermittent groups, which divided into the egg and the milk subgroups. Difference of Egg white and ovomucoid-sIgE or milk and cazein-sIgG4 after 12 +- 2 months from start the OIT between the frequent and the intermittent groups, which divided into the egg and the milk subgroups. Difference of increasing rate of amount of intake in oral food challenge from before the OIT to after the OIT between the frequent group and the intermittent group. Difference of increasing rate of ovomucoid-sIgE in egg allergy and milk-sIgE in milk allergy from before the OIT to after the OIT between the frequent group and the intermittent group. Difference of the FAQ after 12 +- 2 months from start of the OIT between the frequent group and the intermittent group. Difference of the VAS scale for degree of difficulty of intake the foods after 12 +- 2 months from start of the OIT between the frequent group and the intermittent group. | — |
Countries
Japan
Contacts
Hamamatsu University School of Medicine Pediatrics